First Time Loading...

Sera Prognostics Inc
NASDAQ:SERA

Watchlist Manager
Sera Prognostics Inc Logo
Sera Prognostics Inc
NASDAQ:SERA
Watchlist
Price: 10.63 USD 1.92% Market Closed
Updated: May 3, 2024

Sera Prognostics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sera Prognostics Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sera Prognostics Inc
NASDAQ:SERA
Revenue
$306k
CAGR 3-Years
117%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is Sera Prognostics Inc's Revenue?
Revenue
306k USD

Based on the financial report for Dec 31, 2023, Sera Prognostics Inc's Revenue amounts to 306k USD.

What is Sera Prognostics Inc's Revenue growth rate?
Revenue CAGR 3Y
117%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Sera Prognostics Inc have been 117% over the past three years .